RateGain Strategic Partnership with Easebuzz to Strengthen RG Pay Capabilities
RateGain Travel Technologies has announced a strategic partnership with Easebuzz, appointing them as a Gold Partner for RG Pay. This…
Embassy Developments Limited Dissolution of Two Non-Operational Subsidiaries
Embassy Developments Limited has announced the successful strike-off of two of its non-operational step-down subsidiaries, Varali Real Estate…
G R Infraprojects Limited SBI Mutual Fund Reduces Stake by 0.0422%
SBI Mutual Fund has offloaded 40,821 shares of G R Infraprojects Limited through a market sale. Following this transaction on April 17, 2026,…
Shyam Metalics and Energy Limited Expands Pakuria Production Capabilities with New Equipment
Shyam Metalics and Energy Limited has significantly enhanced its production capabilities at the Pakuria facility. The company successfully…
Can Fin Homes Limited Announcement Regarding Leadership Change
Can Fin Homes Limited has officially announced the resignation of Shri Vikram Saha, who served as the company’s Deputy Managing…
GlaxoSmithKline Pharmaceuticals Limited Appoints Vinay Subramanian to Leadership Team
GlaxoSmithKline Pharmaceuticals Limited has announced the appointment of Vinay Subramanian as the Commercial Head – Oncology, effective April…
JSW Steel Successfully Redeems $750 Million in Senior Unsecured Notes
JSW Steel has successfully concluded the full redemption of its $750 million senior unsecured notes. The debt, originally issued by the…
Sammaan Capital Limited Open Offer Update for Public Shareholders
Avenir Investment RSC Ltd, in concert with IHC Capital Holding LLC, has provided an update regarding the ongoing open offer for Sammaan…
Coforge Launches AI-Native Solutions Voyager.AI and Flightflex.AI for Airlines
Coforge has unveiled two advanced AI-native solutions, Voyager.AI and Flightflex.AI, designed to transform airline operations and customer…
Biocon Receives Health Canada Approval for Bosaya™ and Vevzuo™ Biosimilars
Biocon Limited has received a Notice of Compliance (NOC) from Health Canada for its biosimilar products Bosaya™ (denosumab) and Vevzuo™…